NASDAQ:INBS
Intelligent Bio Solutions Inc.
- Stock
Last Close
1.41
26/07 20:00
Market Cap
5.64M
Beta: 4.05
Volume Today
20.11K
Avg: 106.94K
PE Ratio
−0.84
PFCF: −0.86
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 1.01M - | 1.01M 0% | 940.50K 7.30% | -664.11K 170.61% | -1.60M 141.62% | 489.95K 130.53% | ||
average payables | 253.32K - | 533.80K 110.72% | 691.85K 29.61% | 975.65K 41.02% | 1.55M 58.50% | 1.41M 8.78% | ||
average receivables | 18.24K - | 65.49K 259.05% | 57.05K 12.89% | 1.61M 2,729.88% | 2.55M 57.71% | 1.36M 46.66% | ||
book value per share | -7.75 - | -8.17 5.48% | -10.16 24.29% | 20.04 297.26% | 9.03 54.92% | 3.78 58.14% | ||
capex per share | -0.52 - | -0.50 3.03% | ||||||
capex to depreciation | -0.52 - | |||||||
capex to operating cash flow | 0.11 - | 0.07 39.53% | ||||||
capex to revenue | -0.40 - | |||||||
cash per share | 0.74 - | 0.35 52.69% | 0.84 138.74% | 18.52 2,112.06% | 11.24 39.32% | 1.53 86.38% | ||
days of inventory on hand | 384.50 - | |||||||
days payables outstanding | 469.38 - | |||||||
days sales outstanding | 241.95 - | |||||||
debt to assets | 5.30 - | 1.94 63.39% | 2.20 13.67% | 2.07 5.92% | 0.01 99.67% | 0.13 - | ||
debt to equity | -0.60 - | -1.11 85.05% | -1.11 0.52% | -0.99 10.98% | 0.01 101.02% | 0.35 - | ||
dividend yield | ||||||||
earnings yield | -0.04 - | -0.06 46.14% | -0.03 44.01% | -0.21 524.00% | -0.86 315.34% | -3.81 344.96% | ||
enterprise value | 3.48M - | 128.85M 3,604.52% | 129.37M 0.40% | 117.22M 9.39% | 40.94M 65.07% | 1.47M 96.41% | 2.59M 76.26% | |
enterprise value over ebitda | -27.99 - | -19.22 31.33% | -43.32 125.33% | -5.72 86.79% | -0.18 96.91% | -0.35 96.63% | ||
ev to operating cash flow | -23.93 - | -23.20 3.07% | -235.08 913.48% | -3.62 98.46% | -0.44 87.92% | -0.35 19.77% | ||
ev to sales | 2.06 - | |||||||
free cash flow per share | -9.54 - | -9.88 3.58% | -0.98 90.11% | -16.63 1,603.00% | -5.10 69.35% | -7.85 53.91% | ||
free cash flow yield | -0.04 - | -0.04 3.58% | -0.00 90.11% | -0.21 4,663.21% | -0.39 82.41% | -2.82 633.01% | ||
graham net net | -7.26 - | -10.69 47.25% | -12.36 15.58% | 9.61 177.73% | 5.24 45.42% | -4.00 176.25% | ||
graham number | 39.38 - | 48.89 24.15% | 40.78 16.58% | 85.55 109.78% | 47.99 43.91% | 30.01 37.47% | ||
income quality | 1.06 - | 0.75 29.17% | 0.16 79.10% | 1.60 915.23% | 0.40 74.82% | 0.69 71.68% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0.51 Infinity% | |
interest coverage | -10.14 - | -10.12 0.20% | -5.91 41.60% | -5.10 13.79% | -1.11K 21,598.25% | -56.35 94.90% | ||
interest debt per share | 9.38 - | 10.27 9.49% | 10.95 6.69% | 1.81 83.45% | 0.01 99.43% | 1.55 14,996.04% | ||
inventory turnover | 0.95 - | |||||||
invested capital | -0.60 - | -1.11 85.05% | -1.11 0.52% | -0.99 10.98% | 0.01 101.02% | 0.35 - | ||
market cap | 124.43M - | 124.43M 0% | 112.51M 9.58% | 53.51M 52.44% | 9.71M 81.86% | 2.79M 71.23% | ||
net current asset value | -5.91M - | -3.06M 48.18% | -3.98M 29.82% | -5.35M 34.53% | 9.53M 278.17% | 5.06M 46.90% | -2.81M 155.42% | |
net debt to ebitda | -0.96 - | -0.73 23.68% | -1.74 137.25% | 1.76 201.05% | 0.99 43.68% | 0.03 97.27% | ||
net income per share | -8.89 - | -13.00 46.14% | -7.28 44.01% | -16.23 123.10% | -11.33 30.21% | -10.58 6.57% | ||
operating cash flow per share | -9.54 - | -9.88 3.58% | -0.98 90.11% | -16.63 1,603.00% | -4.58 72.47% | -7.34 60.36% | ||
payables turnover | 0.78 - | |||||||
receivables turnover | 1.51 - | |||||||
research and ddevelopement to revenue | 0.40 - | |||||||
return on tangible assets | -2.01 - | -3.15 56.68% | -1.50 52.40% | -0.54 63.98% | -0.67 24.45% | -2.08 210.06% | ||
revenue per share | 1.25 - | |||||||
roe | 1.15 - | 1.59 38.55% | 0.72 54.95% | -0.81 213.10% | -1.25 54.80% | -2.80 123.21% | ||
roic | -9.84 - | -12.93 31.43% | 60.15 565.11% | -0.52 100.87% | -1.25 139.09% | -2.24 78.89% | ||
sales general and administrative to revenue | ||||||||
shareholders equity per share | -7.75 - | -8.17 5.48% | -10.16 24.29% | 20.04 297.26% | 9.03 54.92% | 3.78 58.14% | ||
stock based compensation to revenue | 0.21 - | |||||||
tangible asset value | -5.91M - | -3.06M 48.18% | -3.98M 29.82% | -5.21M 31.12% | 13.55M 359.79% | 6.55M 51.68% | -1.57M 123.96% | |
tangible book value per share | -5.43 - | -7.04 29.82% | -10.22 45.02% | 19.95 295.29% | 8.93 55.25% | -1.56 117.49% | ||
working capital | -5.91M - | -3.06M 48.18% | -3.98M 29.82% | -5.35M 34.53% | 12.70M 337.41% | 6.20M 51.15% | -2.02M 132.57% |
All numbers in USD (except ratios and percentages)